Hepatic impairment Administration of tapentadol resulted in higher exposures and serum ranges to tapentadol in subjects with impaired hepatic function as compared to topics with regular hepatic functionality. The ratio of tapentadol pharmacokinetic parameters with the mild and average hepatic impairment groups compared to the normal hepatic perform group were https://steveh148plh7.webdesign96.com/profile